Gut Microbiota, Bacterial Translocation, and Interactions with Diet: Pathophysiological Links between Major Depressive Disorder and Non-Communicable Medical Comorbidities - PubMed (original) (raw)
Review
doi: 10.1159/000448957. Epub 2016 Nov 25.
Affiliations
- PMID: 27884012
- DOI: 10.1159/000448957
Free article
Review
Gut Microbiota, Bacterial Translocation, and Interactions with Diet: Pathophysiological Links between Major Depressive Disorder and Non-Communicable Medical Comorbidities
Anastasiya Slyepchenko et al. Psychother Psychosom. 2017.
Free article
Abstract
Background: Persistent low-grade immune-inflammatory processes, oxidative and nitrosative stress (O&NS), and hypothalamic-pituitary-adrenal axis activation are integral to the pathophysiology of major depressive disorder (MDD). The microbiome, intestinal compositional changes, and resultant bacterial translocation add a new element to the bidirectional interactions of the gut-brain axis; new evidence implicates these pathways in the patho-aetiology of MDD. In addition, abnormalities in the gut-brain axis are associated with several chronic non-communicable disorders, which frequently co-occur in individuals with MDD, including but not limited to irritable bowel syndrome (IBS), chronic fatigue syndrome (CFS), obesity, and type 2 diabetes mellitus (T2DM).
Methods: We searched the PubMed/MEDLINE database up until May 1, 2016 for studies which investigated intestinal dysbiosis and bacterial translocation (the 'leaky gut') in the pathophysiology of MDD and co-occurring somatic comorbidities with an emphasis on IBS, CFS, obesity, and T2DM.
Results: The composition of the gut microbiota is influenced by several genetic and environmental factors (e.g. diet). Several lines of evidence indicate that gut-microbiota-diet interactions play a significant pathophysiological role in MDD and related medical comorbidities. Gut dysbiosis and the leaky gut may influence several pathways implicated in the biology of MDD, including but not limited to immune activation, O&NS, and neuroplasticity cascades. However, methodological inconsistencies and limitations limit comparisons across studies.
Conclusions: Intestinal dysbiosis and the leaky gut may constitute a key pathophysiological link between MDD and its medical comorbidities. This emerging literature opens relevant preventative and therapeutic perspectives.
© 2016 S. Karger AG, Basel.
Similar articles
- Intestinal Dysbiosis, Gut Hyperpermeability and Bacterial Translocation: Missing Links Between Depression, Obesity and Type 2 Diabetes.
Slyepchenko A, Maes M, Machado-Vieira R, Anderson G, Solmi M, Sanz Y, Berk M, Köhler CA, Carvalho AF. Slyepchenko A, et al. Curr Pharm Des. 2016;22(40):6087-6106. doi: 10.2174/1381612822666160922165706. Curr Pharm Des. 2016. PMID: 27669970 Review. - The Intestinal Microbiota and Irritable Bowel Syndrome.
Ringel Y, Ringel-Kulka T. Ringel Y, et al. J Clin Gastroenterol. 2015 Nov-Dec;49 Suppl 1:S56-9. doi: 10.1097/MCG.0000000000000418. J Clin Gastroenterol. 2015. PMID: 26447966 - [Depressive Disorder and Gut-brain Interaction].
Kunugi H. Kunugi H. Brain Nerve. 2016 Jun;68(6):641-6. doi: 10.11477/mf.1416200455. Brain Nerve. 2016. PMID: 27279162 Japanese. - Irritable bowel syndrome: a gut microbiota-related disorder?
Bhattarai Y, Muniz Pedrogo DA, Kashyap PC. Bhattarai Y, et al. Am J Physiol Gastrointest Liver Physiol. 2017 Jan 1;312(1):G52-G62. doi: 10.1152/ajpgi.00338.2016. Epub 2016 Nov 23. Am J Physiol Gastrointest Liver Physiol. 2017. PMID: 27881403 Free PMC article. Review.
Cited by
- The Antidepressant- and Anxiolytic-Like Effects of the Phosphodiesterase Type-5 Inhibitor Tadalafil are Associated with the Modulation of the Gut-Brain Axis During CNS Autoimmunity.
Duarte-Silva E, Oriá AC, Mendonça IP, Paiva IHR, Leuthier Dos Santos K, Sales AJ, de Souza JRB, Maes M, Meuth SG, Peixoto CA. Duarte-Silva E, et al. J Neuroimmune Pharmacol. 2024 Aug 19;19(1):45. doi: 10.1007/s11481-024-10148-4. J Neuroimmune Pharmacol. 2024. PMID: 39158758 - Examining immune-inflammatory mechanisms of probiotic supplementation in depression: secondary findings from a randomized clinical trial.
Sempach L, Doll JPK, Limbach V, Marzetta F, Schaub AC, Schneider E, Kettelhack C, Mählmann L, Schweinfurth-Keck N, Ibberson M, Lang UE, Schmidt A. Sempach L, et al. Transl Psychiatry. 2024 Jul 24;14(1):305. doi: 10.1038/s41398-024-03030-7. Transl Psychiatry. 2024. PMID: 39048549 Free PMC article. Clinical Trial. - Semaglutide Attenuates Anxious and Depressive-Like Behaviors and Reverses the Cognitive Impairment in a Type 2 Diabetes Mellitus Mouse Model Via the Microbiota-Gut-Brain Axis.
de Paiva IHR, da Silva RS, Mendonça IP, de Souza JRB, Peixoto CA. de Paiva IHR, et al. J Neuroimmune Pharmacol. 2024 Jul 23;19(1):36. doi: 10.1007/s11481-024-10142-w. J Neuroimmune Pharmacol. 2024. PMID: 39042202 - Does "all disease begin in the gut"? The gut-organ cross talk in the microbiome.
Chaudhary PP, Kaur M, Myles IA. Chaudhary PP, et al. Appl Microbiol Biotechnol. 2024 May 21;108(1):339. doi: 10.1007/s00253-024-13180-9. Appl Microbiol Biotechnol. 2024. PMID: 38771520 Free PMC article. Review. - Molecular Mechanisms of Lacticaseibacillus rhamnosus, LGG® Probiotic Function.
Leser T, Baker A. Leser T, et al. Microorganisms. 2024 Apr 14;12(4):794. doi: 10.3390/microorganisms12040794. Microorganisms. 2024. PMID: 38674738 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous